Skip to main content
. Author manuscript; available in PMC: 2016 Dec 6.
Published in final edited form as: Chemosphere. 2013 Feb 28;91(10):1426–1433. doi: 10.1016/j.chemosphere.2013.01.043

Table 3.

Model derived concentrations of fresh weight and lipid adjusted concentrations of POPs in maternal and cord serum across age group.

Compound <20 years 20–24 years 25–29 years ⩾30 years N person-trimester
(<20, 20–24, 25–29, ⩾30 years)a
Fresh Weight POP (95% confidence limits) (pg g−1 serum)
p′,p′-DDT* 124 (64, 242) 98 (55, 178) 230 (128, 410) 269 (134, 538) 38, 70, 65, 38
p′,p′-DDE 2820 (1410, 5630) 1730 (936, 3210) 2430 (1330, 4450) 4130 (2010, 8490) 44, 81, 69, 46
HCB* 20 (15, 29) 22 (16, 29) 25 (18, 33) 37 (26, 52) 30, 59, 52, 33
PCB-74* 7.1 (4.7, 10) 5.1 (3.6, 7.3) 8.0 (5.7, 11) 9.7 (6.4, 15) 35, 65, 60, 37
PCB-99 10 (6.9, 16) 7.6 (5.3, 11) 9.5 (6.7, 14) 12 (8.1, 19) 35, 65, 60, 37
PCB-105 9.7 (6.7, 14) 7.3 (5.3, 10) 8.5 (6.1, 12) 10 (7.1, 15) 35, 65, 60, 37
PCB-118 16 (11, 23) 12 (9.2, 17) 15 (11, 21) 20 (14, 21) 44, 81, 69, 46
PCB-138–158** 32 (23, 44) 31 (23, 41) 37 (28, 49) 58 (42, 80) 44, 81, 69, 46
PCB-146* 7.9 (5.3, 12) 9.8 (6.9, 14) 11 (7.4, 15) 19 (13, 29) 35, 65, 60, 37
PCB-153** 41 (28, 59) 42 (30, 58) 50 (36, 69) 97 (66, 143) 44, 81, 69, 46
PCB-170** 14 (9.3, 20) 15 (11, 21) 20 (14, 28) 43 (29, 64) 44, 81, 69, 46
PCB-180** 28 (20, 40) 32 (24, 44) 41 (30, 56) 92 (64, 134) 44, 81, 69, 46
PCB-183** 4.5 (2.9, 7.1) 5.3 (3.5, 7.8) 6.9 (4.7, 10) 16 (10, 25) 35, 65, 60, 37
PCB-187** 14 (8.7, 21) 13 (8.8, 19) 19 (14, 28) 44 (28, 69) 35, 65, 60, 37
PCB-194** 5.1 (3.5, 7.6) 6.1 (4.3, 8.7) 9.6 (6.8, 13) 22 (15, 33) 35, 65, 60, 37
PCB-196–203** 5.5 (3.7, 8.2) 6.7 (4.7, 9.6) 9.3 (6.6, 13) 20 (13, 30) 35, 65, 60, 37
PCB-199** 5.2 (3.5, 7.7) 5.9 (4.1, 8.3) 8.2 (5.8, 12) 19 (12, 28) 35, 65, 60, 37
Lipid adjusted POPs (95% confidence limits) (ng g−1 lipid)
p′,p′-DDT 22 (11, 44) 19 (10, 34) 39 (22, 71) 44 (22, 88) 38, 70, 65, 38
p′,p′-DDE 487 (239, 994) 319 (169, 601) 413 (223, 769) 702 (334, 1480) 44, 81, 69, 46
HCB* 2.6 (1.9, 3.6) 2.9 (2.2, 3.9) 3.1 (2.3, 4.1) 4.6 (3.3, 6.4) 30, 59, 52, 33
PCB-74 0.90 (0.61, 1.3) 0.71 (0.50, 1.0) 1.0 (0.72, 1.4) 1.2 (0.79, 1.8) 35, 65, 60, 37
PCB-99 1.3 (0.88, 2.0) 1.0 (0.72, 1.5) 1.2 (0.85, 1.7) 1.5 (1.0, 2.3) 35, 65, 60, 37
PCB-105 1.2 (0.84, 1.8) 1.0 (0.72, 1.5) 1.1 (0.79, 1.5) 1.3 (0.88, 1.9) 35, 65, 60, 37
PCB-118 2.8 (2.0, 4.0) 2.3 (1.7, 3.2) 2.7 (1.9, 3.6) 3.4 (2.3, 4.9) 44, 81, 69, 46
PCB-138–158* 5.8 (4.0, 8.2) 5.7 (4.2, 7.9) 6.5 (4.8, 8.9) 10 (7.1, 15) 44, 81, 69, 46
PCB-146* 1.0 (0.69, 1.5) 1.3 (0.95, 1.9) 1.4 (0.97, 1.9) 2.3 (1.6, 3.5) 35, 65, 60, 37
PCB-153* 7.1 (4.9, 10) 7.8 (5.6, 11) 8.6 (6.3, 12) 16 (11, 23) 44, 81, 69, 46
PCB-170** 2.4 (1.7, 3.5) 2.8 (2.0, 3.9) 3.4 (2.5, 4.7) 6.9 (4.7, 10) 44, 81, 69, 46
PCB-180** 5.0 (3.5, 7.1) 6.0 (4.4, 8.2) 7.0 (5.2, 9.5) 15 (11, 22) 44, 81, 69, 46
PCB-183** 0.58 (0.37, 0.90) 0.71 (0.48, 1.1) 0.87 (0.59, 1.3) 1.9 (1.2, 3.0) 35, 65, 60, 37
PCB-187** 1.7 (1.2, 2.6) 1.8 (1.2, 2.5) 2.5 (1.7, 3.5) 5.5 (3.6, 8.3) 35, 65, 60, 37
PCB-194** 0.66 (0.45, 0.97) 0.84 (0.59, 1.2) 1.2 (0.87, 1.7) 2.7 (1.8, 4.1) 35, 65, 60, 37
PCB-196–203** 0.70 (0.47, 1.0) 0.92 (0.65, 1.3) 1.2 (0.84, 1.7) 2.5 (1.6, 3.7) 35, 65, 60, 37
PCB-199** 0.66 (0.45, 0.97) 0.80 (0.57, 1.1) 1.0 (0.75, 1.5) 2.3 (1.6, 3.4) 35, 65, 60, 37
*

Significant difference across age group and education status at p < 0.05.

**

Significant difference across age group and education status at p < 0.01.

a

N breaks down according to trimester for each age group as follows: 1st – 15, 25, 22, 14; 2nd – 11, 20, 19, 12; 3rd – 9, 20, 19, 11; and for those with cord blood – 9, 16, 9, 9 except for HCB: 1st – 11, 22, 14, 11; 2nd – 11, 20, 19, 12; 3rd – 8, 18, 19, 10; and p,p′-DDT: 1st – 15, 25, 22, 14; 2nd – 8, 14, 16, 8; 3rd – 6, 15, 14, 9; and cord blood: 9, 16, 13, 9.